2019
DOI: 10.1155/2019/6371231
|View full text |Cite
|
Sign up to set email alerts
|

Association between Pancreatic Atrophy and Loss of Insulin Secretory Capacity in Patients with Type 2 Diabetes Mellitus

Abstract: Aims. To examine pancreatic volume (PV) changes among patients with different duration of type 2 diabetes and whether pancreatic atrophy was associated with loss of insulin secretory capacity. Methods. This cross-sectional study (203 patients with type 2 diabetes, 93 controls without diabetes) was conducted from January 2016 to December 2017. Patients with type 2 diabetes were divided into 3 groups: recently diagnosed (duration≤2 years), midterm (duration 3-9 years), and long term (duration≥10 years). All the … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2020
2020
2025
2025

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 11 publications
(3 citation statements)
references
References 25 publications
0
3
0
Order By: Relevance
“…with that in non-diabetic control individuals [7,8], supporting a bi-directional interaction between the endocrine and exocrine pancreas; however, discussion of this is beyond the scope of this article. Here we review several forms of pancreatogenic diabetes, highlighting the importance of the exocrine pancreas for the maintenance of pancreatic islet beta cell function and mass.…”
Section: Overviewmentioning
confidence: 84%
“…with that in non-diabetic control individuals [7,8], supporting a bi-directional interaction between the endocrine and exocrine pancreas; however, discussion of this is beyond the scope of this article. Here we review several forms of pancreatogenic diabetes, highlighting the importance of the exocrine pancreas for the maintenance of pancreatic islet beta cell function and mass.…”
Section: Overviewmentioning
confidence: 84%
“…The differential diagnosis for pancreatic atrophy includes chronic pancreatitis, autoimmune pancreatitis, pancreatectomy, immune checkpoint inhibitor therapy, type 2 diabetes mellitus, and pancreatic GVHD [4][5][6][7][8]. Chronic GVHD presenting with pancreatic atrophy is rare, and its natural history and pathophysiology are poorly defined.…”
Section: Discussionmentioning
confidence: 99%
“…While an absolute insulin deficiency characterizes T1DM, the natural history of T2DM is marked by IR in peripheral tissues. Yet, T2DM can also lead to insulin deficiency when insulin production is depleted due to exhaustion of pancreatic synthesis [ 14 , 108 ]. As in T2DM, the state of hyperinsulinemia found in T1DM affects glucose and lipid liver metabolism and triggers pro-inflammatory cascades that produce liver fibrosis and cirrhosis [ 3 , 29 , 109 , 110 ].…”
Section: Diabetes Clinical Phenotypesmentioning
confidence: 99%